Grown Rogue International (GRUSF) Non Operating Interest Expenses (2016 - 2018)
Grown Rogue International's (GRUSF) quarterly Non Operating Interest Expenses came in at -$1.53 in Q3 2018, down 100.01% year-on-year from $15640.2 in Q3 2017, and down 100.25% quarter-over-quarter from $616.03 in Q2 2018.
Grown Rogue International (GRUSF) Non Operating Interest Expenses (2016 - 2018) Analysis & Trends
Grown Rogue International's Non Operating Interest Expenses history runs 3 years deep, the most recent figure standing at -$1.53 for Q3 2018.
- On a quarterly basis, Non Operating Interest Expenses fell 100.01% year-over-year to -$1.53 in Q3 2018; TTM through Aug 2018 was $3166.5, a 95.42% decrease from a year earlier, with the FY2019 full-year figure at -$10165.0, changed N/A from the prior year.
- Non Operating Interest Expenses declined to -$1.53 in Q3 2018 per GRUSF's latest filing, from $616.03 in the prior quarter.
- Across five years, Non Operating Interest Expenses topped out at $42131.9 in Q2 2017 and bottomed at -$1.53 in Q3 2018.
- The 3-year median for Non Operating Interest Expenses is $2221.9 (2016), against an average of $9039.4.
- Across the five-year window, Non Operating Interest Expenses slumped 59.6% in 2017 and slumped 100.01% in 2018, its largest moves.
- Year by year, Non Operating Interest Expenses stood at $3165.0 in 2016, then slumped by 59.6% to $1278.7 in 2017, then sank by 100.12% to -$1.53 in 2018.
- Per Business Quant, the three latest GRUSF Non Operating Interest Expenses figures stand at -$1.53 (Q3 2018), $616.03 (Q2 2018), and $1273.3 (Q1 2018).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2018 | -1.53 |
| May 31, 2018 | 616.03 |
| Feb 28, 2018 | 1,273.26 |
| Nov 30, 2017 | 1,278.73 |
| Aug 31, 2017 | 15,640.22 |
| May 31, 2017 | 42,131.86 |
| Feb 28, 2017 | 8,211.50 |
| Nov 30, 2016 | 3,164.99 |